- D84.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D84.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D84.1 – other international versions of ICD-10 D84.1 may differ.
ICD-10-CM D84.1 is grouped within Diagnostic Related Group(s):
- 642 Inborn and other disorders of metabolism
Applicable To
- C1 esterase inhibitor [C1-INH] deficiency
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D84.1:
- hereditary > Angioedema (allergic) (any site) (with urticaria) T78.3
- hereditary > Angioneurotic edema (allergic) (any site) (with urticaria) T78.3
- hereditary > Bannister\’s disease T78.3
- complement system > Defect, defective Q89.9
- C1 esterase inhibitor (C1-INH) > Deficiency, deficient
- hereditary > angioneurotic (allergic) (any site) (with urticaria) T78.3
- hereditary > circumscribed, acute T78.3
- hereditary > essential, acute T78.3
- hereditary > allergic T78.3
- hereditary > periodic T78.3
- hereditary > Quincke\’s T78.3
- hereditary > urticaria T78.3
- hereditary > Quincke\’s disease or edema T78.3
- hereditary > with angioneurotic edema T78.3
- hereditary > giant T78.3
- hereditary > larynx T78.3